LM
Litton Mark James
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Litton Mark James, 董事长兼首席执行官. Insider active across 3 companies, notably Athira Pharma, Inc.. Cumulatively, 14 reports have been published. Breakdown: 0 buy · 2 sells. Activity tracked since 18 May 2021. The latest transaction was disclosed on 3 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Litton Mark James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
22,254 股0Common StockSEC:0001604834-26-000006:0
10,834 股0Common StockSEC:0001604834-26-000002:0
108,334 股0Common StockSEC:0001415889-25-019069:0
108,333 股0Common StockSEC:0001415889-25-000536:0
20,000 股0Common StockSEC:0001415889-24-022983:0
20,000 股0Common StockSEC:0001415889-24-004153:0
20,000 股0Common StockSEC:0001209191-24-001150:0
662 股@ US$2.743.7% 占其流量Common StockSEC:0001209191-23-005818:0
757 股@ US$7.0611.3% 占其流量Common StockSEC:0001209191-22-039340:0
885 股@ US$12.5136.4% 占其流量Common StockSEC:0001209191-22-005628:0
867 股@ US$14.4538.1% 占其流量Common StockSEC:0001209191-21-052564:0
25,000 股Common StockSEC:0001209191-16-090205:0
17,291 股Common StockSEC:0001209191-16-090205:1
7,709 股Common StockSEC:0001209191-16-090205:2
About Litton Mark James
Litton Mark James is President and CEO. He has 14 filings in total, and in the 14 sampled filings the transactions are Attribution, with a date range from 2016-01-06 to 2026-03-05, purchase volume of EUR 0 and sale volume of EUR 0.